Target engagement and drug residence time can be observed in living cells with BRET

• Published in: Nature communications Vol. 6; no. 1; p. 10091
• Main Authors: Robers, Matthew B., Dart, Melanie L., Woodroofe, Carolyn C., Zimprich, Chad A., Kirkland, Thomas A., Machleidt, Thomas, Kupcho, Kevin R., Levin, Sergiy, Hartnett, James R., Zimmerman, Kristopher, Niles, Andrew L., Ohana, Rachel Friedman, Daniels, Danette L., Slater, Michael, Wood, Monika G., Cong, Mei, Cheng, Yi-Qiang, Wood, Keith V.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 03-12-2015; Nature Publishing Group
• Subjects: 14/34; 38/5; 639/638/309/436/1729; 639/638/92/96; 9/10; Cell Proliferation; Cells - chemistry; Cells - cytology; Cells - drug effects; Energy; Fluorescence Resonance Energy Transfer - methods; HeLa Cells; Histone Deacetylase 1 - chemistry; Histone Deacetylase 1 - metabolism; Histone Deacetylase Inhibitors - chemistry; Histone Deacetylase Inhibitors - pharmacology; Humanities and Social Sciences; Humans; Kinases; Ligands; Luciferases - chemistry; Luciferases - genetics; Luciferases - metabolism; Luminescence; multidisciplinary; Pharmaceutical industry; Pharmaceutical Preparations - chemistry; Physiology; Proteins; Science; Science (multidisciplinary); United States > US
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/ncomms10091

The therapeutic action of drugs is predicated on their physical engagement with cellular targets. Here we describe a broadly applicable method using bioluminescence resonance energy transfer (BRET) to reveal the binding characteristics of a drug with selected targets within intact cells. Cell-permeable fluorescent tracers are used in a competitive binding format to quantify drug engagement with the target proteins fused to Nanoluc luciferase. The approach enabled us to profile isozyme-specific engagement and binding kinetics for a panel of histone deacetylase (HDAC) inhibitors. Our analysis was directed particularly to the clinically approved prodrug FK228 (Istodax/Romidepsin) because of its unique and largely unexplained mechanism of sustained intracellular action. Analysis of the binding kinetics by BRET revealed remarkably long intracellular residence times for FK228 at HDAC1, explaining the protracted intracellular behaviour of this prodrug. Our results demonstrate a novel application of BRET for assessing target engagement within the complex milieu of the intracellular environment.
Drug molecules operate through physical interaction with specific cellular targets, and understanding this interaction is important for mechanisms and the potential therapeutic effect of drug candidates. Here, the authors show that bioluminescence resonance energy transfer can be used to monitor the intracellular engagement of a drug with its target.